Skip to main content
NIH funding notice PA-14-308

Platform Delivery Technologies for Nucleic Acid Therapeutics (R41/R42)

Closed on September 7, 2016.

Posted
August 4, 2014
Close date
September 7, 2016
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,176,099 in first-year total cost, median $322,946.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 BCMB-G (10)]1
  2. Special Emphasis Panel[ZRG1 BST-F (10)]1
  3. Special Emphasis Panel[ZRG1 IDM-X (10)]1
  4. Special Emphasis Panel[ZRG1 IMST-S (12)]1
  5. Special Emphasis Panel[ZRG1 IMST-T (12)]1

Most frequent institutions

  1. ACTORIUS PHARMACEUTICALS, LLC1
  2. ATGC, INC.1
  3. BOHEMICA PHARMACEUTICALS, LLC1
  4. INITOS PHARMACEUTICALS, LLC1
  5. MOLECULAR EXPRESS, INC.1
Competing awards under PA-14-308 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2017A nanoparticle delivery system for CRISPR/Cas9 based therapeutics1R42TR001711-01A1MA, PETER XATGC, INC., MI$225,000ZRG1
2016Development of nucleic acid delivery platform based on polymeric CXCR4 antagonists1R41TR001312-01A1LI, JINGBOHEMICA PHARMACEUTICALS, LLC, NE$347,546ZRG1
2016Screening the Ribosome for New Target Sites1R41AI120303-01A1ARYA, DEV PRIYANUBAD, LLC, SC$325,000ZRG1
2016Development of Chol-DsiRNA Polyplexes to Improve the Therapy of Breast Cancer1R41TR001902-01A1VETRO, JOSEPH ANTHONEYACTORIUS PHARMACEUTICALS, LLC, NE$324,985ZRG1
2016Development of a novel platform to enhance intracellular bioavailability of antisense morpholino oligomers1R41AI122462-01AMANNA, IAN JAMESMOULTON, HONG MNAJIT TECHNOLOGIES, INC., OR$318,591ZRG1
2015Development of a Gene and Oligonucleotide Delivery System1R41TR001338-01FUJII, GARYMOLECULAR EXPRESS, INC., CA$322,946ZRG1
2015Development of Small Molecules that Enhance the Delivery and the Pharmacological Effects of Oligonucleotides1R41TR001330-01FRYE, STEPHEN VERNONJULIANO, RUDOLPHINITOS PHARMACEUTICALS, LLC, NC$312,031ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PA-14-308: Platform Delivery Technologies for Nucleic Acid Therapeutics (R41/R42) | ScienceDex | ConductScience